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INTRODUCTION
Meningiomas are the most common primary intracranial 
neoplasms in adults, which account for over a third of pri-
mary intracranial neoplasms, with an incident rate of 8.03 
per 100,000 population [1]. The 2016 World Health Organi-
zation (WHO) classification categorizes meningiomas into 3 
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Background    To compare the diagnostic performance of two-dimensional (2D) and three-dimensional 
(3D) fractal dimension (FD) and lacunarity features from MRI for predicting the meningioma grade.
Methods    This retrospective study included 123 meningioma patients [90 World Health Organi-
zation (WHO) grade I, 33 WHO grade II/III] with preoperative MRI including post-contrast T1-weighted 
imaging. The 2D and 3D FD and lacunarity parameters from the contrast-enhancing portion of the tu-
mor were calculated. Reproducibility was assessed with the intraclass correlation coefficient. Multivari-
able logistic regression analysis using 2D or 3D fractal features was performed to predict the meningi-
oma grade. The diagnostic ability of the 2D and 3D fractal models were compared. 
Results    The reproducibility between observers was excellent, with intraclass correlation coef-
ficients of 0.97, 0.95, 0.98, and 0.96 for 2D FD, 2D lacunarity, 3D FD, and 3D lacunarity, respectively. 
WHO grade II/III meningiomas had a higher 2D and 3D FD (p=0.003 and p<0.001, respectively) and 
higher 2D and 3D lacunarity (p=0.002 and p=0.006, respectively) than WHO grade I meningiomas. 
The 2D fractal model showed an area under the curve (AUC), accuracy, sensitivity, and specificity of 
0.690 [95% confidence interval (CI) 0.581-0.799], 72.4%, 75.8%, and 64.4%, respectively. The 3D 
fractal model showed an AUC, accuracy, sensitivity, and specificity of 0.813 (95% CI 0.733-0.878), 
82.9%, 81.8%, and 70.0%, respectively. The 3D fractal model exhibited significantly better diagnostic 
performance than the 2D fractal model (p<0.001).
Conclusion    The 3D fractal analysis proved superiority in diagnostic performance to 2D fractal 
analysis in grading meningioma.
Key Words Fractals; Magnetic resonance imaging; Meningioma.
grades [2]. Using modern WHO criteria, 70–75% of surgi-
cally resected meningiomas are grade I (benign), 20–30% are 
grade II (atypical), and 1–3% are grade III (anaplastic) [2]. 
Compared to benign (WHO grade I) meningiomas, atypical 
(WHO grade II) or anaplastic (WHO grade III) tumors have 
an aggressive clinical behavior, an increased risk of tumor re-
currence, as well as an poor prognosis [3]. 
The ability to preoperatively differentiate between WHO 
grade I and WHO grade II/III meningiomas has crucial clini-
cal ramifications. Patients with WHO grade II/III meningio-
mas could benefit from early and complete resection [4]. 
Moreover, according to the European Association of Neuro-
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Oncology guideline, incidentally discovered menigiomas on 
MRI can be managed by observation [5]; thus, the histological 
grade may not be confirmed. Thus, noninvasive prediction of 
the meningioma grade may support clinical decision-making 
by providing information on whether observation should be 
performed. However, currently, the value of meningioma 
grading on the basis of neuroimaging has been low [6]. Con-
ventional imaging features are subjective [7], and diffusion and 
perfusion imaging has shown contradictory results [8-10]. 
Fractal features are image descriptors that mathematically 
measures the geometrical complexity [11,12]. In particular, 
the uniqueness of fractal features lies in its ability to quantify 
natural objects with high structural complexities that are 
poorly represented by the conventional Euclidean geometry, 
thereby allowing analysis of underlying tissue biology reflect-
ed as morphological information. Fractal dimension (FD) 
and lacunarity are the two parameters used in fractal analysis. 
FD describes the intrinsic shape of an object; as the FD in-
creases, the complexity increases [12]. Lacunarity is a geomet-
ric measure that represents the degree of rotational (or trans-
lational) invariance and gappiness [12]. Several studies have 
performed fractal analysis on differentiating various brain tu-
mors with promising results [13-15], but most studies have 
analyzed only two-dimensional (2D) or three-dimensional 
(3D) fractal features. By encompassing the entire tumor, 3D 
fractal features may potentially provide a more comprehen-
sive assessment of the fractal properties of a tumor and show 
better diagnostic performance than 2D fractal features. How-
ever, there has been no previous study that compared the di-
agnostic accuracy of 2D and 3D fractal models. 
We hypothesized that 3D fractal features may exhibit true 
fractal behavior and show superiority in grading meningioma 
than 2D fractal features. Thus, the purpose of this study was 
to compare the diagnostic performance of 2D and 3D FD and 
lacunarity features for predicting the grade of meningiomas.
MATERIALS AND METHODS
Patient population
This retrospective study was approved by the Yonsei Univer-
sity Heath System Institutional Review Board, and a waiver of 
informed consent was obtained. One hundred thirty-one me-
ningioma cases in which pathological confirmation and pre-
operative conventional MRI were performed between June 
2009 and January 2018 were included in this study. Exclusion 
criteria were as follows: 1) patients with a past history of brain 
surgery (n=6), and 2) patients who have undergone tumor 
embolization or gamma knife surgery before MRI examina-
tion (n=2). A total of 123 patients were included in this study 
(100 females and 23 males; mean age: 57.9±13.0 years).
MRI protocol
MRI scans was performed using a 3-T MRI scanner (Achie-
va, Philips Medical Systems, Best, the Netherlands) with an 
eight-channel head coil. The preoperative MRI protocol in-
cluded T1-weighted [repetition time (TR)/echo time (TE): 
2,000/10 ms; field of view: 230 mm; section thickness: 5 mm; 
matrix: 320×198] and post-contrast T1-weighted (T1C) images 
(TR/TE: 2000/10 ms; field of view: 250 mm; section thickness: 
2 mm; and matrix: 256×256). T1C images were acquired after 
the administration of 0.1 mL/kg of gadolinium-based contrast 
material (Gadovist; Bayer, Leverkusen, Germany).
Pathologic diagnosis
According to the 2016 WHO criteria, pathological diagnosis 
and meningioma grading was performed by a neuropatholo-
gist [12]. The mitosis count was evaluated using the mitotic 
marker phosphohistone-H3. The mitosis index was determined 
by counting the number of unequivocal mitotic figures in 10 
consecutive high-power fields (×400) containing the highest 
number of mitoses. The Ki-67 labeling index was estimated.
Segmentation of the tumor
Tumor segmentation was performed by a neuroradiologist 
(Y.W.P.), blinded to the clinical and histopathologic results. 
The regions of interests were segmented using an open source 
software platform for medical image informatics (3D slicer, 
version 4.10.2; available at: http://slicer.org). Regions of inter-
ests were drawn on every tumor slice on T1C images, using an 
intensity threshold-based semiautomatic method. Gross cys-
tic, necrotic, or hemorrhagic areas were avoided using T1-
weighted and T1C images. To test the interobserver reproduc-
ibility, images from 20 patients were randomly selected and 
separately segmented by another neuroradiologist (S.S.A.). 
2D and 3D fractal analysis
Computation of the 2D and 3D box-counting FD and lacu-
narity values were performed using the mask after binarization 
[16]. FD was calculated by using a 2D square and 3D cube box-
counting method, with multiple grid offsets for all possible box 
start locations. Lacunarity was calculated by averaging the 
square of coefficient of variation values of multiple 2D square 
and 3D cube boxes that included a part of the binary mask [17]. 
Since the optimal box size was unknown, both FD and lacunar-
ity values were computed with different 2D and 3D box sizes, 
ranging from 20 to 27 isotropic pixels and voxels. The mean 2D 
and 3D FD and lacunarity values were calculated in each pa-
tient and were used in further analysis (Details of FD and lacu-
narity calculations are available in the Supplementary Material 
in the online-only Data Supplement) [16-19]. Fig. 1 shows the 
schematic for tumor segmentation and fractal analyses. 
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RESULTS
The clinical, histopathological characteristics and fractal 
features of the 123 patients are summarized in Table 1. There 
were 90 WHO grade I meninigiomas and 33 WHO grade II/
III meningiomas. Among WHO grade I meningiomas, 44 
were transitional, 27 meningothelial, 10 fibroblastic, four 
psammomatous, two angiomatous, two microcystic, and one 
secretory. Among WHO grade II/III meningiomas, 29 atypi-
cal and four anaplastic meningiomas. Patients with WHO 
grade II/III meningiomas had a lower prevalence of skull 
base location than WHO grade I meningiomas (12.1% vs. 
30.0%, p=0.043).
WHO grade II/III meningiomas had higher 2D FD (1.4 
vs. 1.3, p=0.003), higher 2D lacunarity (2.8 vs. 2.7, p=0.002), 
higher 3D FD (2.0 vs. 1.9, p<0.001), and higher 3D lacunari-
ty (5.2 vs. 4.8, p=0.006) than WHO grade I meningiomas. 
Fig. 2 shows the boxplots of the 2D and 3D fractal features 
according to different meningioma grades. 
Reproducibility of 2D and 3D fractal features
The reproducibility between observers was excellent for 
both 2D and 3D fractal features, with intraclass correlation 
coefficients of 0.97 [95% confidence interval (CI) 0.96–0.98] 
for 2D FD, 0.95 (95% CI 0.94–0.96) for 2D lacunarity, 0.98 
(95% CI 0.97–0.99) for 3D FD, and 0.96 (95% CI 0.95–0.97) 
for 3D lacunarity.
Statistical analysis
The baseline characteristics were compared between pa-
tients with WHO grade I and WHO grade II/III meningio-
mas using the independent t-test or Mann-Whitney U-test 
for continuous variables according to normality, and chi-
square test for categorical variables. The interobserver repro-
ducibility of fractal parameters was assessed by two-way in-
terclass correlation. 
Univariate and multivariable logistic regression analyses 
were performed using 2D or 3D fractal features to find the 
features that are significantly associated with WHO grade II/
III meningiomas. Variables of interest in the univariate analy-
sis (p<0.05) were included in the multivariable models by us-
ing the backward selection method. Because the aim of this 
study was to compare the diagnostic accuracy of 2D and 3D 
fractal models, 2D fractal models were consisted of significant 
2D fractal features in the univariate results, and 3D fractal 
models were consisted of significant 3D fractal features in the 
univariate results, respectively. We estimated the area under 
the curve (AUC) to assess the predictive ability of the multi-
variable models. The diagnostic performance of the 2D fractal 
model was compared with that of a 3D fractal model. De-
Long’s method was used to compare the AUCs among the 2D 
fractal model and 3D fractal model [20].
All statistical analyses were performed using the MedCalc 
Statistical Software version 16.2.0 (https://www.medcalc.org). 
A p-value <0.05 was considered statistically significant.
Fig. 1. The schematic of segmentation and fractal analysis in our study. A: A post-contrast T1-weighted imaging of a representative case 
with meningioma. B: After segementation of the enhancing portion of the tumor, two-dimensional and three-dimensional fractal analysis 
were performed by using box-counting methods.
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Table 1. Clinical and imaging characteristics according to the meningioma grade
Variable WHO grade I meningioma (n=90) WHO grade II/III meningioma (n=33)    p value*
Age (yr) 56.54±11.9 61.7±15.3 0.051
Sex 0.140
Female 76 (84.4) 24 (72.7)
Male 14 (15.6) 9 (27.3)
Mitosis count 1.1±0.3 7.5±5.7 <0.001
Ki-67 labeling index 1.7±0.9 7.7±5.7 <0.001
Skull-base location 27 (30.0) 4 (12.1) 0.043
2D Fractal parameters
2D FD 1.3±0.1 1.4±0.2 0.003
2D lacunarity 2.7±0.3 2.8±0.3 0.002
3D Fractal parameters
3D FD 1.9±0.2 2.0±0.2 <0.001
3D lacunarity 4.8±0.7 5.2±0.8 0.006
Data are presented either numbers of patients (%) or mean±standard deviation. *Calculated from the Student t-test or Mann-Whitney U-
test for continuous variables, and chi-square test for categorical variables. WHO, World Health Organization; FD, fractal dimension; 2D, 
two-dimensional; 3D, three-dimensional
Univariate and multivariable logistic analyses of 2D 
and 3D fractal models for prediction of meningioma 
grades
On univariate analysis, higher 2D FD [odds ratio 
(OR)=235.8 (95% CI 5.3–10,547.9), p=0.005], higher 3D FD 
[OR=97.9 (95% CI 6.9–1,381.1), p=0.001], and higher 3D 
lacunarity [OR=2.2 (95% CI 1.2–3.8), p=0.008] were associ-
ated with WHO grade II/III meningiomas. Because the sig-
nificant variable on univariate analysis was included in the 
2D fractal model, 2D FD [OR=235.8 (95% CI 5.3–10,547.9), 
p=0.005] was the only independent variable for predicting 
the meningioma grade in the 2D fractal model. In multivari-
able analysis for 3D fractal model, 3D FD [OR=1,250.3 (95% 
CI 42.2–37,022.8), p<0.001] and lacunarity [OR 4.0 (95% CI 
2.0–8.1), p<0.001] were independent variables for predicting 
the meningioma grade (Univariate and multivariable results 
are on Table 2). 
The 2D fractal model showed an AUC, accuracy, sensitivi-
ty, and specificity of 0.690 (95% CI 0.581–0.799), 72.4%, 
75.8%, and 64.4%, respectively. The 3D fractal model showed 
an AUC, accuracy, sensitivity, and specificity of 0.813 (95% 
CI 0.733–0.878), 82.9%, 81.8%, and 70.0%, respectively. In 
the comparison of the predictive power for WHO grade II/
III meningiomas in the two multivariable models, 3D fractal 
model exhibited significantly better diagnostic performance 
than 2D fractal model (p<0.001) (Table 3, Fig. 3). 
DISCUSSION
Spatial heterogeneity is an important property displayed by 
tumors that has biological consequences. In this study, we 
comparatively analyzed the diagnostic accuracy of 2D and 3D 
fractal features in grading meningioma, showing that 3D 
fractal features show significantly better performance in grad-
ing meningioma. To the best of our knowledge, this is the first 
study comparing the diagnostic accuracy of 2D and 3D frac-
tal features in medical imaging. In routine clinical practice, 
surgery is usually recommended for patients with mass effect 
or symptoms [5]. However, WHO grade II/III meningiomas 
patients may benefit from early operation even in the absence 
of these radiological or clinical findings. Our results provide a 
quantitative method to preoperatively differentiate WHO 
grade I from WHO grade II/III meningiomas, and may aid 
clinical decision making before treatment.
Both the 2D and 3D FD were significantly higher in WHO 
grade II/III meningiomas than in WHO grade I meningiomas, 
suggesting that WHO grade II/III meningiomas exhibit a 
more complex structure. Also, the lacunarity of WHO grade 
II/III meningiomas was significantly higher than that of WHO 
grade I meningiomas, suggesting that the necrosis which are 
visualized as gaps in the tumor lesion may increase its rota-
tional variance. However, 2D lacunarity was not a significant 
predictor in the univariate analysis, and 3D fractal model 
showed significantly superior performance to 2D fractal mod-
el. Because meningioma exhibits a complex 3D structure, 2D 
fractal analysis shows limitations in that it is performed with 
an averaging of parameter values under a particular angle view 
of this complex 3D structure, which may not be fully represen-
tative of the whole tumor and supports the case for investigat-
ing 3D fractal features [21,22]. In our results, 2D and 3D FD 
and lacunarity differed in values, and 3D fractal features pro-
vided values with larger magnitude than 2D fractal features, 
which reflects the volume assessed. 
Previous studies have demonstrated that meningiomas with 
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Table 2. Univariate and multivariable logistic regression analysis for predictors of meningioma grade
Variable
Univariate Multivariable
OR (95% CI) p value OR (95% CI) p value
Age (yr) 1.0 (1.0–1.1) 0.055 - -
Female sex 0.5 (0.2–1.3) 0.491 - -
Skull-base location 0.3 (0.1–1.0) 0.051 - -
2D fractal parameters
2D FD 235.8 (5.3–10,547.9) 0.005      235.8 (5.3–10,547.9)    0.005*
2D lacunarity 2.3 (0.7–7.4) 0.161 - -
3D fractal parameters
3D FD 97.9 (6.9–1,381.1) 0.001      1,250.3 (42.2–37,022.8) <0.001†
3D lacunarity 2.2 (1.2–3.8) 0.008 4.0 (2.0–8.1) <0.001†
*Multivariable logistic regression results which were only performed on 2D fractal features. †Multivariable logistic regression results which 
were only performed on 3D fractal features. OR, odds ratio; CI, confidence interval; FD, fractal dimension; 2D, two-dimensional; 3D, three-
dimensional














































a high proliferative potential may exhibit highly heterogeneous 
distributions of proliferating cells in the tumor, resulting in ir-
regular shapes [23,24]. Our study provides a quantitative meth-
od to assess this complexity in grading meningioma. Some recent 
studies have focused on radiomics features for differentiating 
the meningioma grade [25,26], but fractal features have not 
been routinely implemented in the previous radiomics studies 
[26-30]. Apart from other radiomics features, fractal features 
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are known to be relatively stable, as shown in our study as high 
reproducibility. Moreover, radiomics studies are prone to over-
fitting due to high dimensionality and high-probability of false-
positive rate, and the large number of features requires intensive 
computational resources [31]. We used a conventional T1C se-
quence that is routinely included in the MRI rather than ad-
vanced imaging techniques, such as diffusion tensor imaging 
or amide proton transfer imaging [7,26,32], suggesting a more 
feasible methodology.
Our study has several limitations. First, our study was a ret-
rospective study based on a single institution with a limited 
sample size. Future studies with a larger sample is necessary 
for validation. Second, there is data imbalance in the WHO 
grade I and WHO grade  II/III meningiomas. However, our 
proportion of meningioma grades are in concordance to the 
proportion reported according to the 2016 WHO classifica-
tion [2], as this is an retrospective study. Third, comparison of 
WHO grade II and grade III meningiomas were not per-
formed, due to small data size. 
In conclusion, we compared the diagnostic performance 2D 
and 3D fractal features in grading meningioma. The 3D fractal 
analysis proved superiority in diagnostic performance to 2D 
fractal analysis in grading meningioma, and may be useful for 
treatment planning.
Supplementary Materials
The online-only Data Supplement is available with this arti-
cle at https://doi.org/10.14791/btrt.2020.8.e3.
Conflicts of Interest
The authors have no potential conflicts of interest.  
Acknowledgments
This research received funding from the Basic Science Research Pro-
gram through the National Research Foundation of Korea (NRF) funded 
by the Ministry of Science, Information and Communication Technologies 
& Future Planning (2017R1D1A1B03030440). This work was supported 
under the framework of international cooperation program managed by 
National Research Foundation of Korea (NRF-2018K2A9A2A06020642). 
This research was supported financially by the fund of Korean Society for 
Neuro Oncology.
ORCID iDs
Yae Won Park  https://orcid.org/0000-0001-8907-5401
Soopil Kim  https://orcid.org/0000-0001-8937-6263
REFERENCES
1. Ostrom QT, Gittleman H, Xu J, et al. CBTRUS statistical report: pri-
mary brain and other central nervous system tumors diagnosed in the 
United States in 2009-2013. Neuro Oncol 2016;18(suppl_5):v1-75.
2. Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Or-
ganization classification of tumors of the central nervous system: a 
summary. Acta Neuropathol 2016;131:803-20.
3. Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barn-
holtz-Sloan JS. Descriptive epidemiology of World Health Organiza-
tion grades II and III intracranial meningiomas in the United States. 
Neuro Oncol 2015;17:1166-73.
4. Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge 
base, treatment outcomes, and uncertainties. A RANO review. J Neuro-
surg 2015;122:4-23.
5. Goldbrunner R, Minniti G, Preusser M, et al. EANO guidelines for the 
diagnosis and treatment of meningiomas. Lancet Oncol 2016;17:e383-91.
6. Nowosielski M, Galldiks N, Iglseder S, et al. Diagnostic challenges in 
meningioma. Neuro Oncol 2017;19:1588-98.
7. Joo B, Han K, Choi YS, et al. Amide proton transfer imaging for differen-
tiation of benign and atypical meningiomas. Eur Radiol 2018;28:331-9.
8. Sanverdi SE, Ozgen B, Oguz KK, et al. Is diffusion-weighted imaging 
useful in grading and differentiating histopathological subtypes of me-
ningiomas? Eur J Radiol 2012;81:2389-95.
9. Azizyan A, Eboli P, Drazin D, Mirocha J, Maya MM, Bannykh S. Dif-
ferentiation of benign angiomatous and microcystic meningiomas with 
extensive peritumoral edema from high grade meningiomas with aid of 
diffusion weighted MRI. Biomed Res Int 2014;2014:650939. 
10. Zhang H, Rödiger LA, Shen T, Miao J, Oudkerk M. Preoperative sub-
typing of meningiomas by perfusion MR imaging. Neuroradiology 
Table 3. Comparison of diagnostic performance between 2D fractal model and 3D fractal model for predicting the meningioma grade
Models AUC (95% CI) Accuracy (%) Sensitivity (%) Specificity (%) p value*
2D fractal model 0.690 (0.581–0.799) 72.4 75.8 64.4 Reference
3D fractal model 0.813 (0.733–0.878) 82.9 81.8 70.0 <0.001
*p-value refers to the significance among the differences of the AUCs between the 2D fractal and 3D fractal models. AUC, area under the 
curve; CI, confidence interval; 2D, two-dimensional; 3D, three-dimensional
Fig. 3. Receiver operating characteristic curves of 2D fractal mod-
els and 3D fractal models for predicting meningioma grades. 2D, 
two-dimensional; 3D, three-dimensional.
100-Specificity (%)
















42  Brain Tumor Res Treat  2020;8(1):36-42
Comparison of 2D and 3D Fractal Analyses for Meningioma Grade
2008;50:835-40. 
11. Lee G, Lee HY, Park H, et al. Radiomics and its emerging role in lung 
cancer research, imaging biomarkers and clinical management: state 
of the art. Eur J Radiol 2017;86:297-307.
12. Lennon FE, Cianci GC, Cipriani NA, et al. Lung cancer-a fractal 
viewpoint. Nat Rev Clin Oncol 2015;12:664-75. 
13. Liu S, Wang Y, Xu K, et al. Relationship between necrotic patterns in 
glioblastoma and patient survival: fractal dimension and lacunarity 
analyses using magnetic resonance imaging. Sci Rep 2017;7:8302.
14. Liu S, Fan X, Zhang C, et al. MR imaging based fractal analysis for dif-
ferentiating primary CNS lymphoma and glioblastoma. Eur Radiol 
2019;29:1348-54.
15. Smitha KA, Gupta AK, Jayasree RS. Fractal analysis: fractal dimension 
and lacunarity from MR images for differentiating the grades of glio-
ma. Phys Med Biol 2015;60:6937-47. 
16. Falconer K. Fractal geometry: mathematical foundations and applica-
tions. Hoboken: John Wiley & Sons; 2004.
17. Plotnick RE, Gardner RH, O’Neill RV. Lacunarity indices as measures 
of landscape texture. Landsc Ecol 1993;8:201-11.
18. Metze K. Fractal dimension of chromatin: potential molecular diag-
nostic applications for cancer prognosis. Expert Rev Mol Diagn 2013; 
13:719-35.
19. Kane AJ, Sughrue ME, Rutkowski MJ, et al. Anatomic location is a risk 
factor for atypical and malignant meningiomas. Cancer 2011;117:1272-8.
20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas 
under two or more correlated receiver operating characteristic curves: 
a nonparametric approach. Biometrics 1988;44:837-45.
21. Sanghera B, Banerjee D, Khan A, et al. Reproducibility of 2D and 3D 
fractal analysis techniques for the assessment of spatial heterogeneity 
of regional blood flow in rectal cancer. Radiology 2012;263:865-73.
22. Park YW, Kim S, Ahn SS, et al. Magnetic resonance imaging-based 
3-dimensional fractal dimension and lacunarity analyses may predict 
the meningioma grade. Eur Radiol 2020 Apr 9 [Epub]. Available at: 
https://doi.org/10.1007/s00330-020-06788-8.
23. Nakasu S, Nakasu Y, Nakajima M, Matsuda M, Handa J. Preoperative 
identification of meningiomas that are highly likely to recur. J Neuro-
surg 1999;90:455-62.
24. Siegers HP, Zuber P, Hamou MF, van Melle GD, de Tribolet N. The 
implications of the heterogeneous distribution of Ki-67 labelled cells 
in meningiomas. Br J Neurosurg 1989;3:101-7.
25. Coroller TP, Bi WL, Huynh E, et al. Radiographic prediction of meningi-
oma grade by semantic and radiomic features. PLoS One 2017;12: 
e0187908.
26. Park YW, Oh J, You SC, et al. Radiomics and machine learning may ac-
curately predict the grade and histological subtype in meningiomas using 
conventional and diffusion tensor imaging. Eur Radiol 2019;29:4068-76.
27. Park YW, Han K, Ahn SS, et al. Whole-tumor histogram and texture 
analyses of DTI for evaluation of IDH1-mutation and 1p/19q-codele-
tion status in World Health Organization grade II gliomas. AJNR Am 
J Neuroradiol 2018;39:693-8.
28. Park YW, Choi YS, Ahn SS, Chang JH, Kim SH, Lee SK. Radiomics 
MRI phenotyping with machine learning to predict the grade of lower-
grade gliomas: a study focused on nonenhancing tumors. Korean J 
Radiol 2019;20:1381-9.
29. Park CJ, Choi YS, Park YW, et al. Diffusion tensor imaging radiomics in 
lower-grade glioma: improving subtyping of isocitrate dehydrogenase 
mutation status. Neuroradiology 2020;62:319-26.
30. Park YW, Han K, Ahn SS, et al. Prediction of IDH1-mutation and 
1p/19q-codeletion status using preoperative MR imaging phenotypes 
in lower grade gliomas. AJNR Am J Neuroradiol 2018;39:37-42.
31. Park JE, Park SY, Kim HJ, Kim HS. Reproducibility and generalizabili-
ty in radiomics modeling: possible strategies in radiologic and statisti-
cal perspectives. Korean J Radiol 2019;20:1124-37.
32. Toh CH, Castillo M, Wong AM, et al. Differentiation between classic 
and atypical meningiomas with use of diffusion tensor imaging. AJNR 
Am J Neuroradiol 2008;29:1630-5.
